BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26095132)

  • 1. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
    Rando J; Broering D; Olson JE; Marco C; Evans SB
    Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Police officer attitudes towards intranasal naloxone training.
    Ray B; O'Donnell D; Kahre K
    Drug Alcohol Depend; 2015 Jan; 146():107-10. PubMed ID: 25468814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Police Officers Can Safely and Effectively Administer Intranasal Naloxone.
    Fisher R; O'Donnell D; Ray B; Rusyniak D
    Prehosp Emerg Care; 2016; 20(6):675-680. PubMed ID: 27218446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipping an urban hospital police and security team with Narcan.
    Driscoli J; Michelman B
    J Healthc Prot Manage; 2016 Oct; 32(2):1-4. PubMed ID: 29638270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal naloxone administration for treatment of opioid overdose.
    Robinson A; Wermeling DP
    Am J Health Syst Pharm; 2014 Dec; 71(24):2129-35. PubMed ID: 25465584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid overdose prevention with intranasal naloxone among people who take methadone.
    Walley AY; Doe-Simkins M; Quinn E; Pierce C; Xuan Z; Ozonoff A
    J Subst Abuse Treat; 2013 Feb; 44(2):241-7. PubMed ID: 22980450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Training law enforcement to respond to opioid overdose with naloxone: Impact on knowledge, attitudes, and interactions with community members.
    Wagner KD; Bovet LJ; Haynes B; Joshua A; Davidson PJ
    Drug Alcohol Depend; 2016 Aug; 165():22-8. PubMed ID: 27262898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.
    Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J
    J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
    Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
    Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.
    Heavey SC; Delmerico AM; Burstein G; Moore C; Wieczorek WF; Collins RL; Chang YP; Homish GG
    J Community Health; 2018 Apr; 43(2):304-311. PubMed ID: 28852906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.
    Kirane H; Ketteringham M; Bereket S; Dima R; Basta A; Mendoza S; Hansen H
    J Subst Abuse Treat; 2016 Oct; 69():44-9. PubMed ID: 27568509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
    Mundin G; McDonald R; Smith K; Harris S; Strang J
    Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?
    Weber JM; Tataris KL; Hoffman JD; Aks SE; Mycyk MB
    Prehosp Emerg Care; 2012; 16(2):289-92. PubMed ID: 22191727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone administration by law enforcement officers in New York State (2015-2020).
    Pourtaher E; Payne ER; Fera N; Rowe K; Leung SJ; Stancliff S; Hammer M; Vinehout J; Dailey MW
    Harm Reduct J; 2022 Sep; 19(1):102. PubMed ID: 36123614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.
    Dietze P; Cantwell K
    Addiction; 2016 Apr; 111(4):584-6. PubMed ID: 26995168
    [No Abstract]   [Full Text] [Related]  

  • 20. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
    Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
    Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.